336 related articles for article (PubMed ID: 28191719)
1. 5-Aminolevulinic acid-mediated photodynamic therapy for bladder cancer.
Inoue K
Int J Urol; 2017 Feb; 24(2):97-101. PubMed ID: 28191719
[TBL] [Abstract][Full Text] [Related]
2. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
[TBL] [Abstract][Full Text] [Related]
3. Protoporphyrin IX induced by 5-aminolevulinic acid in bladder cancer cells in voided urine can be extracorporeally quantified using a spectrophotometer.
Nakai Y; Anai S; Onishi S; Masaomi K; Tatsumi Y; Miyake M; Chihara Y; Tanaka N; Hirao Y; Fujimoto K
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):282-8. PubMed ID: 25595357
[TBL] [Abstract][Full Text] [Related]
4. Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light source.
Waidelich R; Beyer W; Knüchel R; Stepp H; Baumgartner R; Schröder J; Hofstetter A; Kriegmair M
Urology; 2003 Feb; 61(2):332-7. PubMed ID: 12597941
[TBL] [Abstract][Full Text] [Related]
5. Aminolevulinic acid for photodynamic therapy of bladder carcinoma cells.
Bachor R; Reich E; Rück A; Hautmann R
Urol Res; 1996; 24(5):285-9. PubMed ID: 8931293
[TBL] [Abstract][Full Text] [Related]
6. Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer.
Hagiya Y; Fukuhara H; Matsumoto K; Endo Y; Nakajima M; Tanaka T; Okura I; Kurabayashi A; Furihata M; Inoue K; Shuin T; Ogura S
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):288-95. PubMed ID: 23993855
[TBL] [Abstract][Full Text] [Related]
7. Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells.
Steinbach P; Kriegmair M; Baumgartner R; Hofstädter F; Knüchel R
Urology; 1994 Nov; 44(5):676-81. PubMed ID: 7974943
[TBL] [Abstract][Full Text] [Related]
8. The effect of photodynamic therapy on rat urinary bladder with orthotopic urothelial carcinoma.
Grönlund-Pakkanen S; Wahlfors J; Talja M; Kosma VM; Pakkanen TM; Ala-Opas M; Alhava E; Moore RB
BJU Int; 2003 Jul; 92(1):125-30. PubMed ID: 12823396
[TBL] [Abstract][Full Text] [Related]
9. Optimization of differential photodynamic effectiveness between normal and tumor urothelial cells using 5-aminolevulinic acid-induced protoporphyrin IX as sensitizer.
Seidl J; Rauch J; Krieg RC; Appel S; Baumgartner R; Knuechel R
Int J Cancer; 2001 Jun; 92(5):671-7. PubMed ID: 11340570
[TBL] [Abstract][Full Text] [Related]
10. Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A multicenter phase III study.
Nakai Y; Inoue K; Tsuzuki T; Shimamoto T; Shuin T; Nagao K; Matsuyama H; Oyama M; Furuse H; Ozono S; Miyake M; Fujimoto K
Int J Urol; 2018 Aug; 25(8):723-729. PubMed ID: 29999205
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy and topical aminolevulinic acid: an overview.
Gupta AK; Ryder JE
Am J Clin Dermatol; 2003; 4(10):699-708. PubMed ID: 14507231
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
13. PpIX fluorescence kinetics and increased skin damage after intracutaneous injection of 5-aminolevulinic acid and repeated illumination.
Thissen MR; de Blois MW; Robinson DJ; de Bruijn HS; Dutrieux RP; Star WM; Neumann HA
J Invest Dermatol; 2002 Feb; 118(2):239-45. PubMed ID: 11841539
[TBL] [Abstract][Full Text] [Related]
14. 5-Aminolevulinic acid in intraoperative photodynamic therapy of bladder cancer (results of multicenter trial).
Filonenko EV; Kaprin AD; Alekseev BY; Apolikhin OI; Slovokhodov EK; Ivanova-Radkevich VI; Urlova AN
Photodiagnosis Photodyn Ther; 2016 Dec; 16():106-109. PubMed ID: 27671517
[TBL] [Abstract][Full Text] [Related]
15. Wavelength dependency of photodynamic effects after sensitization with 5-aminolevulinic acid in vitro and in vivo.
Szeimies RM; Abels C; Fritsch C; Karrer S; Steinbach P; Bäumler W; Goerz G; Goetz AE; Landthaler M
J Invest Dermatol; 1995 Nov; 105(5):672-7. PubMed ID: 7594642
[TBL] [Abstract][Full Text] [Related]
16. Expression of ferrochelatase has a strong correlation in protoporphyrin IX accumulation with photodynamic detection of bladder cancer.
Nakai Y; Tatsumi Y; Miyake M; Anai S; Kuwada M; Onishi S; Chihara Y; Tanaka N; Hirao Y; Fujimoto K
Photodiagnosis Photodyn Ther; 2016 Mar; 13():225-232. PubMed ID: 26226642
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy using 5-aminolevulinic acid triggered DNA damage of adenocarcinoma breast cancer and hepatocellular carcinoma cell lines.
Abo-Zeid MAM; Abo-Elfadl MT; Mostafa SM
Photodiagnosis Photodyn Ther; 2018 Mar; 21():351-356. PubMed ID: 29355735
[TBL] [Abstract][Full Text] [Related]
18. Current status of photodynamic technology for urothelial cancer.
Inoue K; Fukuhara H; Yamamoto S; Karashima T; Kurabayashi A; Furihata M; Hanazaki K; Lai HW; Ogura SI
Cancer Sci; 2022 Feb; 113(2):392-398. PubMed ID: 34750935
[TBL] [Abstract][Full Text] [Related]
19. Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit.
Ahmad S; Aboumarzouk O; Somani B; Nabi G; Kata SG
BJU Int; 2012 Dec; 110(11 Pt B):E596-600. PubMed ID: 22758907
[TBL] [Abstract][Full Text] [Related]
20. Key transporters leading to specific protoporphyrin IX accumulation in cancer cell following administration of aminolevulinic acid in photodynamic therapy/diagnosis.
Lai HW; Nakayama T; Ogura SI
Int J Clin Oncol; 2021 Jan; 26(1):26-33. PubMed ID: 32875514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
